Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS broadens defibrillator query

This article was originally published in The Gray Sheet

Executive Summary

Agency is gathering further evidence on the necessity of threshold-testing at the time of implantation. The second round of comments will inform CMS' review of appropriate ICD use, the agency notes June 23. CMS also is seeking evidence on the risks and benefits of adding anti-tachycardia pacing to ICD functions. Considerations include the risk of an additional lead and whether justification exists for developing a patient registry "to collect information to better identify predictors of ICD firing for ventricular fibrillation as a proxy for sudden cardiac death." Commenters should base answers on published literature rather than clinical practice...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020460

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel